Literature DB >> 18995957

Myricetin directly targets JAK1 to inhibit cell transformation.

Takuma Kumamoto1, Makoto Fujii, De-Xing Hou.   

Abstract

JAK1/STAT3 pathway has been suggested to play a role in cell transformation and carcinogenesis. In the present study, we found that myricetin (3, 3', 4', 5, 5', 7-hexahydroxyflavone), a typical flavonol existing in many fruits and vegetables, could directly bind to JAK1/STAT3 molecules to inhibit cell transformation in epidermal growth factor (EGF)-activated mouse JB6 P(+) cells. Colony assay revealed that myricetin had the strongest inhibitory effect on cell transformation among three flavonols including myricetin, quercetin and kaempferol. Molecular data revealed that myricetin inhibited DNA- binding and transcriptional activity of STAT3. Furthermore, myricetin inhibited the phosphorylation of STAT3 at Tyr705 and Ser727. Cellular signaling analyses revealed that EGF could induce the phosphorylation of Janus Kinase (JAK) 1, but not JAK2. Myricetin inhibited the phosphorylation of JAK1 and increased the autophosphorylation of EGF receptor (EGFR). Moreover, ex vivo and in vitro pull-down assay revealed that myricetin bound to JAK1 and STAT3, but not EGFR. Affinity data further demonstrated that myricetin had a higher affinity for JAK1 than STAT3. Thus, our data indicate that myricetin might directly target JAK1 to block cell transformation in mouse JB6 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18995957     DOI: 10.1016/j.canlet.2008.09.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Screening and biological evaluation of myricetin as a multiple target inhibitor insulin, epidermal growth factor, and androgen receptor; in silico and in vitro.

Authors:  Pushpendra Singh; Felix Bast
Journal:  Invest New Drugs       Date:  2015-04-19       Impact factor: 3.850

2.  Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Matthew R Young; Elaine Lanza; Arthur Schatzkin; Nancy H Colburn; Amanda J Cross
Journal:  Eur J Cancer Prev       Date:  2011-03       Impact factor: 2.497

Review 3.  Molecular targets of phytochemicals for cancer prevention.

Authors:  Ki Won Lee; Ann M Bode; Zigang Dong
Journal:  Nat Rev Cancer       Date:  2011-02-10       Impact factor: 60.716

Review 4.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

5.  Akt is a direct target for myricetin to inhibit cell transformation.

Authors:  Takuma Kumamoto; Makoto Fujii; De-Xing Hou
Journal:  Mol Cell Biochem       Date:  2009-06-06       Impact factor: 3.396

6.  Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.

Authors:  Julia Wachter; Daniel Neureiter; Beate Alinger; Martin Pichler; Julia Fuereder; Christian Oberdanner; Pietro Di Fazio; Matthias Ocker; Frieder Berr; Tobias Kiesslich
Journal:  Int J Biol Sci       Date:  2011-11-07       Impact factor: 6.580

7.  Hydroxylation decoration patterns of flavonoids in horticultural crops: chemistry, bioactivity and biosynthesis.

Authors:  Yilong Liu; Jiafei Qian; Jiajia Li; Mengyun Xing; Donald Grierson; Chongde Sun; Changjie Xu; Xian Li; Kunsong Chen
Journal:  Hortic Res       Date:  2022-01-20       Impact factor: 7.291

Review 8.  Myricetin: A Dietary Molecule with Diverse Biological Activities.

Authors:  Deepak Kumar Semwal; Ruchi Badoni Semwal; Sandra Combrinck; Alvaro Viljoen
Journal:  Nutrients       Date:  2016-02-16       Impact factor: 5.717

9.  Discovery of γ-Mangostin as an Amyloidogenesis Inhibitor.

Authors:  Takeshi Yokoyama; Mitsuharu Ueda; Yukio Ando; Mineyuki Mizuguchi
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.996

10.  In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.

Authors:  Alexander Aliper; Aleksey V Belikov; Andrew Garazha; Leslie Jellen; Artem Artemov; Maria Suntsova; Alena Ivanova; Larisa Venkova; Nicolas Borisov; Anton Buzdin; Polina Mamoshina; Evgeny Putin; Andrew G Swick; Alexey Moskalev; Alex Zhavoronkov
Journal:  Aging (Albany NY)       Date:  2016-09-24       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.